✦ LIBER ✦

977 - A randomized single-institution study of high-dose chemotherapy with cyclophosphamide, thiotepa and carboplatin (CTC) in apical node-positive breast cancer

✍ Scribed by S. Rodenhuis; D.J. Richel; J.W. Baars; J.H. Schomagel; J.H. Borger; C. Koning; E. Rutgers

Book ID: 117665219
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 261 KB
Volume: 33
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(97)85731-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of a multi-course high-do

Phase II study of a multi-course high-dose chemotherapy regimen incorporating cyclophosphamide, thiotepa, and carboplatin in stage IV breast cancer

✍ Schrama, J G; Baars, J W; Holtkamp, M J; Schornagel, J H; Beijnen, J H; Rodenhui 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 117 KB

Phase II trial of sequential high-dose c

Phase II trial of sequential high-dose chemotherapy with paclitaxel, melphalan and cyclophosphamide, thiotepa and carboplatin with peripheral blood progenitor support in women with responding metastatic breast cancer

✍ Vahdat, L T; Balmaceda, C; Papadopoulos, K; Frederick, D; Donovan, D; Sharpe, E; 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 108 KB

Improved Disease-Free and Overall Surviv

Improved Disease-Free and Overall Survival with Dose-Dense Chemotherapy Compared with Conventional Chemotherapy in the Adjuvant Treatment of Node-Positive Breast Cancer: Results of a Randomized Study (CALGB 9741)

✍ Kavita Maung; Joyce A. O'Shaughnessy; George W. Sledge Jr. 📂 Article 📅 2003 🏛 CIG Media Group, LP. 🌐 English ⚖ 108 KB

681 - Conventional-dosage of Adriamycin

681 - Conventional-dosage of Adriamycin and Paclitaxel vs. High-dose-chemotherapy with Cyclophosphamide, Mitoxantrone and VP-16 in the treatment of metastatic breast cancer — A randomized study

✍ G. Dingeldein; B. Flath; O. Sezer; D. Lüftner; H.-D. Mergenthaler; K. Possinger 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 256 KB

Adjuvant six cycles of high-dose adriamy

Adjuvant six cycles of high-dose adriamycin, cyclophosphamide, methotrexate, 5-fluorouracil (ACMF) vs. 12 cycles of low-dose acmf with tamoxifen for premenopausal, node-positive breast cancer patients: Results of a prospective randomized study

✍ Dr. Takashi Fukutomi; Sadako Akashi; Takeshi Nanasawa; Hiroshi Yamamoto 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 398 KB

A prospective randomized study was conducted to compare the adjuvant efficacy of six cycles of high-dose ACMF (Adriamycin, ADM; cyclophosphamide, CPA; methotrexate, MTX; 5-fluorouracil, 5-FU) with that of 12 cycles of low-dose ACMF in premenopausal, node-positive breast cancer patients. The six-cycl